PMID: 8611143Feb 1, 1996Paper

The phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C translocation in rat adipocytes

The Biochemical Journal
M L StandaertR V Farese

Abstract

We questioned whether phosphatidylinositol 3-kinase (PI 3-kinase) and protein kinase C (PKC) function as interrelated signalling mechanisms during insulin action in rat adipocytes. Insulin rapidly activated a phospholipase D that hydrolyses phosphatidylcholine (PC), and this activation was accompanied by increases in diacylglycerol and translocative activation of PKC-alpha and PKC-beta in the plasma membrane. Wortmannin, an apparently specific PI 3-kinase inhibitor, inhibited insulin-stimulated, phospholipase D-dependent PC hydrolysis and subsequent translocation of PKC-alpha and PKC-beta to the plasma membrane. Wortmannin did not inhibit PKC directly in vitro, or the PKC-dependent effects of phorbol esters on glucose transport in intact adipocytes. The PKC inhibitor RO 31-8220 did not inhibit PI 3-kinase directly or its activation in situ by insulin, but inhibited both insulin-stimulated and phorbol ester-stimulated glucose transport. Our findings suggest that insulin acts through PI 3-kinase to activate a PC-specific phospholipase D and causes the translocative activation of PKC-alpha and PKC-beta in plasma membranes of rat adipocytes.

Citations

May 23, 2001·Experimental Biology and Medicine·R V Farese
Dec 4, 2003·Diabetes/metabolism Research and Reviews·Ping Huang, Michael A Frohman
Sep 24, 2014·Pharmacological Reviews·Ronald C BruntzH Alex Brown
Mar 30, 2002·Molecular Endocrinology·Michael LeitgesMichael Letiges
Oct 10, 2002·American Journal of Physiology. Cell Physiology·Seema SaksenaPradeep K Dudeja
Jun 21, 2011·Journal of Receptor and Signal Transduction Research·Maya F Serhan, Sawsan I Kreydiyyeh
Jun 20, 2015·International Journal of Endocrinology·Nataliya A Babenko, Vitalina S Kharchenko
Apr 26, 2002·Journal of Cardiovascular Pharmacology·Akira KudohTomoko Takazawa
Jun 18, 2002·American Journal of Physiology. Endocrinology and Metabolism·Robert V Farese
Nov 19, 2003·European Journal of Biochemistry·Irmelin ProbstPeter Bütikofer
Aug 28, 1999·The Journal of Biological Chemistry·C Z Yang, M Mueckler
Oct 12, 2004·The Journal of Biological Chemistry·Robert V StahelinWonhwa Cho
Mar 4, 2000·The Journal of Biological Chemistry·M EmotoM P Czech
Sep 28, 2002·Journal of Cardiovascular Pharmacology·Akira KudohTomoko Takazawa
Jan 14, 1999·The American Journal of Physiology·T IshizukaK Yasuda
Jan 28, 1999·Biochemical and Biophysical Research Communications·C A MillarG W Gould
Sep 25, 2001·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·M IshizawaK Yasuda
May 2, 1998·Biochimica Et Biophysica Acta·G Arthur, R Bittman
Aug 11, 2007·Biochimica Et Biophysica Acta·Jiro Nakamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.